Home · Medication guides
Step therapy

Sleep medications denied: Belsomra, Quviviq and Dayvigo

Insomnia drugs are commonly gated behind older generics, sleep-study documentation or quantity limits. Here is what the criteria ask for and how an appeal answers them.

BelsomraQuviviqDayvigoLunestaAmbienzolpidemeszopiclonesuvorexantdaridorexant
Cove Health·

Denials of newer insomnia medications are usually a step rule rather than a clinical judgment: the plan covers older hypnotics and wants those tried first, and the record has to show that they were. Where the trials happened but were never written down in the form the policy asks for, the appeal is documentary rather than argumentative.

Why was my sleep medication denied?

Step therapy. Coverage policies for orexin receptor antagonists and other newer agents commonly require documented trials of generic hypnotics first, at an adequate dose and duration.

Diagnostic documentation. Some policies ask that other sleep disorders be considered or excluded, or that the diagnosis be recorded in a particular way, before a hypnotic is covered.

Quantity limits. These drugs are frequently capped per month, and a regimen that exceeds the cap produces a denial of the amount rather than the drug.

Controlled-substance rules. Where an agent is scheduled, refill timing and quantity rules apply on top of the coverage policy and can produce a rejection at the counter that is not a coverage decision at all.

Duplicate therapy. Plans generally will not cover two hypnotics concurrently, and a request that reads as an overlap is denied on that ground.

What does the denial letter actually mean?

"Step therapy required" names the drugs the plan wants tried first, and the appeal is a step therapy override claiming a specific exception ground: already tried and failed, intolerance, contraindication, expected ineffectiveness, or stability on the current regimen.

"Criteria not met" means a documented element the policy names was missing. "Quantity limit exceeded" means coverage exists and the amount does not. "Non-formulary" points at a formulary exception, and "not medically necessary" at the medical necessity route.

The notice carries the deadline and the address, and those govern your case.

What can I do in the next 48 hours?

The general steps are in the first 48 hours after a denial. For this class, gather three things.

Ask the plan in writing for the step protocol and the coverage policy for the drug. Ask your clinician's office for the record of every hypnotic tried, with dates, doses, durations and why each was stopped, and for the note where any adverse effect was reported. Where a sleep study exists, or where the clinician has documented why one is not indicated, ask for that too, because policies frequently reference it.

If the route is unclear from the notice, the free denial check narrows it in about a minute.

How does a physician-written appeal help for sleep medication denials?

Step denials are answered by naming the exception ground the plan's own policy provides and then evidencing it. A licensed physician reviews the records, says candidly whether the case has merit, and where it does writes a letter that claims that ground by name, sets out the trial history with dates and doses, documents intolerance or contraindication where the record supports it, addresses any diagnostic criterion the policy applies, argues the clinical rationale for the quantity requested where a limit is at issue, and cites the guidelines and labeling behind the prescribed agent.

Cove Health cannot guarantee results, but you should not have to reconstruct years of trials on your own.

Cove Health provides advocacy services. Information on this site is general information, not legal or medical advice. Cove Health is not a law firm and does not provide legal representation, and submission of records does not guarantee a particular outcome.

Frequently asked questions

Step therapy denials for this category, answered.

Why does my plan want me to try an older sleep drug first? +
Step therapy is a cost rule, and the older hypnotics are inexpensive generics. Policies for the newer orexin receptor antagonists commonly require documented trials of one or more of those first, at an adequate dose and duration.
I stopped a sleep drug because of next-day grogginess or a bad reaction. Does that count? +
Documented intolerance is a recognised exception ground in most step policies. What it needs is a record: the drug, the dose, the effect, and the note or visit where it was reported, rather than a recollection in the appeal itself.
Why is a sleep study or a diagnosis of another sleep disorder being asked for? +
Some policies ask that other conditions be considered or excluded before covering a hypnotic, because treatment differs by condition. Where a study exists, attaching it usually resolves the criterion; where the clinician has documented why one is not indicated, that reasoning belongs in the file.
The plan limits me to a small number of tablets per month. Can that be appealed? +
Quantity limits are a coverage rule and plans generally provide a route to request an exception. The request is argued from documented clinical need and the prescriber's rationale for the quantity sought.
Does it matter that I have other conditions affected by poor sleep? +
It can, because criteria and the clinical rationale often turn on the whole picture rather than the sleep complaint alone. Comorbid conditions only count where they are recorded, so it is worth asking that they be documented.

Still have a question?

Keep reading

Other commonly denied medications

Biologics denied: Humira, Enbrel and the TNF inhibitorsTNF inhibitor denials usually come from a step therapy rule that asks you to fail a cheaper drug first. Here is what the rule requires, what an exception has to show, and what to gather before you appeal.Step therapyRead the guide →CGRP migraine injections denied: Aimovig, Emgality and AjovyPreventive migraine injectables are usually denied because a plan wants older preventives tried first, or because the headache diary the criteria ask for was never submitted. Here is how that appeal works.Step therapyRead the guide →JAK inhibitors denied: Rinvoq, Xeljanz and OlumiantJAK inhibitors usually sit behind a step requirement that asks for a biologic first, plus safety documentation. Here is what the criteria ask for and how an override request answers them.Step therapyRead the guide →